Published on 09 Sep 2022

Helping BioMedtech start-ups grow through co11aboration and innovation

To facilitate the clinical adoption of new technologies that will create value for patients, NTU Singapore, the Agency for Science, Technology and Research (A*STAR), and National Healthcare Group (NHG) today launched co11ab Novena (co11ab), an incubator to support biomedical technology (BioMedtech) start-ups make the leap from R&D into commercialisation of their innovations.

Located in NTU Lee Kong Chian School of Medicine (LKCMedicine), the S$15 million incubator aims to be a national innovation and translational hub that brings together research, clinical, and venture creation activities, creating an environment that spurs knowledge sharing, innovation, and collaboration.

The collaboration was inked today between NTU, A*STAR, and NHG.

Marking the launch is a new partnership between co11ab and the Singapore Medtech Consortium to provide start-ups at co11ab with equipment and expertise that a start-up may not have in-house to accelerate product development. 

Related media releases

Media coverage